ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 256927 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 256927; 2) Community: the network communities that were significantly associated with the response to NSC 256927; 3) Molecule: the relationships between components within communities and NSC 256927; 4) MDR: the compounds that were significantly associated with the NSC 256927.

NSC Compound Enrichment Correlation
NSC 682436 Naphth[2,3-d]oxazol-9(4H)-one, 4-[(2-aminocyclohexyl) imino]-2-methyl-, acetate 0.0283958753782626 0.27056032
NSC 701100 2H-1-Benzopyran-2-one, 6-chloro-3-[imidazo[1,2-a]pyridin-2-yl]- 0.0283958753782626 -0.069302155
NSC 749147 Null 0.0283958753782626 0.55283395
NSC 81052 Streptonigrin analog (MeO-N3) 0.0283958753782626 0.59693372
NSC 670678 Glutamic acid, N-[4-[[[2-(ethoxycarbonyl)-3-quinoxalinyl] amino]phenyl]carbonyl]-, diethyl ester 0.0287230216965523 -0.32676229
NSC 752384 Null 0.0287230216965523 -0.262028
NSC 2626 Tenox PG 0.0287230216965525 -0.0054148955
NSC 112535 s-Triazine, 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-[m-[2-(p-nitro-phenoxy)ethoxy]phenyl]-, monohydrochloride (8CI) 0.030556149892922 0.27102089
NSC 142587 Null 0.030556149892922 0.30445671
NSC 226080 Sirolimus 0.030556149892922 0.029636715
Total:80  Current:45    [First] [Prev] [Next] [Last]